![]() |
市场调查报告书
商品编码
1466548
器官移植市场:按类型和最终用户划分 - 全球预测 2024-2030Organ Transplantation Market by Type (Heart Transplantation, Kidney Transplantation, Liver Transplantation), End User (Hospitals & Care Providers, Transplant Centers) - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年器官移植市场规模为164.5亿美元,预计2024年将达到180.7亿美元,2030年将达到326.9亿美元,复合年增长率为10.30%。
器官移植市场包括与人体器官的采购、分配和移植给需要器官替代治疗的患者相关的所有活动。相关人员包括器官捐赠组织、移植中心、医疗机构、提供抗排斥药物的製药公司以及开发人造器官和辅助技术的生物医学公司。最终用途包括用捐赠者的功能性器官替换有缺陷的器官的临床程序、医疗追踪以及移植前后的持续患者照护。器官移植市场的成长有几个因素,包括器官移植手术数量的增加、慢性病盛行率的增加和器官衰竭案例的加速,以及器官捐赠者和合法化途径的开拓。然而,一些限制和挑战影响了器官移植的采用,包括器官捐赠者短缺、治疗成本上升、器官排斥和移植后併发症的风险,以及对我所给予的器官移植的社会和伦理问题。同时,器官移植方法的技术进步、器官捐赠意识的提高、器官和组织3D生物列印的进步以及降低排斥和併发症风险的个人化免疫抑制通讯协定预计将在未来几年继续带来潜在的商机。
主要市场统计 | |
---|---|
基准年[2023] | 164.5亿美元 |
预测年份 [2024] | 180.7亿美元 |
预测年份 [2030] | 326.9亿美元 |
复合年增长率(%) | 10.30% |
由于肾臟病类型增加,肾臟移植数量迅速增加
心臟移植是在其他手术治疗失败时对末期心臟衰竭或严重冠状动脉疾病患者进行的重要外科手术。由于供体心臟有限,心臟移植的需求通常超过供应。肾臟移植涉及用捐赠者的健康肾臟取代患病的肾臟。由于高血压和糖尿病引起的肾臟疾病的盛行率不断增加,这种类型的移植需求量很大。肾臟移植通常比其他器官移植更常见,因为肾臟来自活体捐赠者,这可以增加捐赠者库。肝臟移植是移植捐赠者的全部或部分肝臟的手术。此手术主要适用于因肝硬化或丙型肝炎等疾病导致的末期肝病或急性肝功能衰竭的患者。肝臟移植市场包括免疫抑制药物和涉及器官保存解决方案的生技公司。肺移植用捐赠者的健康肺部替换患病的肺。它通常用于患有严重、危及生命的肺部疾病的患者,例如慢性阻塞性肺病(COPD)、囊肿纤维化或肺纤维化。胰臟移植通常用于治疗第 1 型糖尿病,并且经常与肾臟移植合併使用。这项手术可以消除糖尿病患者对胰岛素治疗的需求。
最终使用者:由于我们员工的专业知识和技能,移植中心的器官移植正在不断发展。
医院和护理人员在器官移植过程中发挥着至关重要的作用。他们是潜在接受者的第一个联络人,并促进治疗诊断和移植后护理。他们的偏好包括确保器官活力的高品质和可靠的器官储存和运输系统、先进的手术设备以及用于复杂移植手术的手术室技术。移植中心是专门从事器官移植的专业机构。就人员和技术专长而言,它们往往是更先进的设施。移植中心使用最新的免疫抑制剂方案和治疗方法,以及先进的组织配对技术,以根据您的需求更好地匹配捐赠者和接受者。
区域洞察
由于强大的医疗基础设施、成熟的器官捐赠网络以及对研发的大量投资,美洲器官移植呈现快速成长。美国消费者对器官捐赠和器官移植的认知度较高,相关服务的需求也较高。南美洲的器官移植市场正在扩大,以巴西和阿根廷等国家为首。政府提高器官捐赠率和改善移植服务的措施正在推动市场发展。欧洲拥有强大的医疗基础设施和全面的器官移植政策,西班牙等国家因其高效的捐赠者管理系统而受到认可。先进技术的引入和专业移植服务的可用性正在促进该市场的成长。由于医疗保健支出的增加和法律规范的不断发展,中东器官移植市场出现成长。文化和宗教因素显着影响消费行为。在非洲,基础设施的挑战和医疗保健的差异阻碍了器官移植。然而,在一些地区建立移植计画的进展面临资金、公众意识和监管障碍等障碍。由于慢性病的增加、医疗保健支出的增加以及政府促进器官捐赠的努力,亚太地区的器官移植市场正在迅速开拓。由于对医疗基础设施的大量投资和不断壮大的中阶,中国的器官移植事业正在迅速成长。日本拥有完善的医疗保健体系,但面临人口老化和对器官捐赠的文化抵制等挑战。印度是一个复杂的器官移植市场,在获得医疗服务方面存在巨大差异。需求不断增加,尤其是在都市区,私立医院在移植服务方面处于主导。
FPNV定位矩阵
FPNV定位矩阵对于评估器官移植市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对器官移植市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.器官移植市场的市场规模与预测是多少?
2.在器官移植市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.器官移植市场的技术趋势和法规结构是什么?
4.器官移植市场主要厂商的市场占有率是多少?
5.进入器官移植市场的合适型态和策略手段是什么?
[181 Pages Report] The Organ Transplantation Market size was estimated at USD 16.45 billion in 2023 and expected to reach USD 18.07 billion in 2024, at a CAGR 10.30% to reach USD 32.69 billion by 2030.
The organ transplantation market encompasses all activities related to procuring, distributing, and transplanting human organs to patients requiring organ replacement therapy. It includes stakeholders such as organ donation agencies, transplant centers, healthcare facilities, pharmaceutical companies that provide anti-rejection medications, and biomedical companies that create artificial organs and support technologies. Application and end-use involve clinical procedures for replacing a faulty organ with a functioning organ from a donor, medical follow-up, and ongoing patient care for pre-and post-transplant scenarios. Several factors contribute to the growth of the organ transplantation market, including an increasing number of organ transplantation surgeries, the increasing prevalence of chronic diseases and accelerating cases of organ failure, and the development of legalized channels for organ donors and transplants. However, several limitations and challenges impact the adoption of organ transplantation, such as shortage of organ donors and high cost of treatment, risk of organ rejection and post-transplant complications, and social and ethical concerns in organ transplantation. On the other hand, technological advancement in organ transplantation methods, increasing awareness of organ donation, advancements in 3D bioprinting of organs and tissues, and personalized immunosuppression protocols to reduce the risk of rejection and complications present potential opportunities for the organ transplantation market in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 16.45 billion |
Estimated Year [2024] | USD 18.07 billion |
Forecast Year [2030] | USD 32.69 billion |
CAGR (%) | 10.30% |
Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
Heart transplantation is a critical surgical procedure performed on patients with end-stage heart failure or extreme coronary artery disease when other surgical treatments fail. The demand for heart transplants usually outweighs the supply due to the limited availability of donor hearts. Kidney transplantation involves replacing a diseased kidney with a healthy one from a donor. This type of transplant is in high demand owing to the increasing incidence of kidney diseases, often resulting from hypertension and diabetes. Kidney transplants are usually more common than other organ transplants because kidneys can be donated by living donors, increasing the donor pool. Liver transplantation is the surgical alteration of a diseased liver with a complete or partial liver from a donor. This procedure is primarily indicated for patients with end-stage liver disease or acute liver failure, often due to conditions such as cirrhosis or hepatitis C. The market for liver transplantation includes pharmaceuticals for immunosuppression, along with biotechnology companies engaged in organ preservation solutions. Lung transplantation replaces diseased lungs with healthy lungs from a donor. It is generally reserved for individuals suffering from severe, life-threatening lung conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, or pulmonary fibrosis. Pancreas transplantation is usually performed to treat type 1 diabetes, often in conjunction with kidney transplantation. This procedure can eliminate the need for insulin therapy for diabetic patients.
End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
Hospitals and care providers play a pivotal role in the organ transplantation process. They are potential recipients' first point of contact and facilitate diagnosing treatment and post-transplant care. Their need-based preferences include high-quality, reliable organ preservation and transport systems to ensure organ viability, advanced surgical equipment, and operating room technology tailored for complex transplant operations. Transplant centers are specialized facilities that focus exclusively on organ transplants. They tend to be more advanced in terms of the specialization of staff and technology. Transplant centers' need-based preferences include the latest immunosuppressive drug protocols, treatments, and advanced tissue-typing technology to ensure better donor-recipient matches.
Regional Insights
The Americas represents a rapid growth in organ transplantation due to a robust healthcare infrastructure, established organ donation networks, and significant investments in research and development. Consumers in the US show high awareness regarding organ donation and transplantation, leading to substantial demand for related services. The organ transplantation market in South America is expanding, with countries such as Brazil and Argentina at the forefront. The markets are driven by governmental initiatives to increase organ donation rates and improve transplantation services. Europe exhibits a robust healthcare infrastructure and comprehensive organ transplant policies, with countries, including Spain, recognized for their efficient donor management systems. The incorporation of advanced technologies and the availability of specialized transplantation services contribute to the growth of this market. The Middle East showcases a growing organ transplant market driven by increasing healthcare spending and evolving regulatory frameworks. Cultural and religious factors significantly impact consumer behavior concerning organ donation and transplants. In Africa, organ transplantation activities are hindered by infrastructure challenges and disparities in healthcare. However, some regions are making strides in establishing transplantation programs but face obstacles with funding, public awareness, and regulatory hurdles. The APAC region is experiencing rapid development in the organ transplantation market, driven by the increasing prevalence of chronic diseases, rising healthcare expenditures, and government initiatives to promote organ donation. China is rapidly growing in organ transplantation due to substantial investments in healthcare infrastructure and a growing middle class. Japan has a well-established healthcare system, with specific challenges related to an aging population and cultural resistance to organ donation. India represents a complex organ transplant market with vast disparities in access to healthcare services. There's growing demand, particularly within urban centers, with private hospitals leading transplantation services.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Organ Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organ Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, AbbVie Inc., Arthrex, Inc., Artivion, Inc., Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BiolifeSolutions, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Dr. Franz Kohler Chemie GmbH, Exactech, Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Medtronic PLC, NHS Blood and Transplant, Novartis AG, Organ Recovery Systems, Organovo Holdings, Inc., OrganOx Limited, Pfizer Inc., Plexision, Preservation Solutions, Inc., Sanofi S.A., Stryker Corporation, Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., and Xvivo Perfusion AB.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Organ Transplantation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organ Transplantation Market?
3. What are the technology trends and regulatory frameworks in the Organ Transplantation Market?
4. What is the market share of the leading vendors in the Organ Transplantation Market?
5. Which modes and strategic moves are suitable for entering the Organ Transplantation Market?